11
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Visual semi-quantitative assessment of liver tumour burden for neuroendocrine tumour liver metastases is often used in patient management and outcome. However, published data on the reproducibility of these evaluations are lacking.

          Objective

          The aim of this study was to evaluate the interobserver and intraobserver agreement of a visual semi-quantitative assessment of liver tumour burden using CT scan.

          Methods

          Fifty consecutive patients (24 men and 26 women, mean aged 54 years) were retrospectively reviewed by four readers (two senior radiologists, one junior radiologist and one gastroenterologist) who assessed the liver tumour burden based on a visual semi-quantitative method with four classes (0–10, 11–25, 26–50 and ≥50%). Interobserver and intraobserver agreement were assessed by weighted kappa coefficient and percentage of agreement. The intraclass correlation was calculated.

          Results

          Agreement among the four observers for the evaluation of liver tumour burden was substantial, ranging from 0.62 to 0.73 ( P < 0.0001). The intraclass coefficient was 0.977 ( P < 0.0001). Intraobserver agreement was 0.78 and ICC was 0.97.

          Conclusion

          Reproducibility of the visual semi-quantitative evaluation of liver tumour burden is good and is independent of the level of experience of the readers. We therefore suggest that clinical studies in patients with neuroendocrine liver metastases use this method to categorise liver tumour burden.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: found

          ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

            • Record: found
            • Abstract: found
            • Article: found

            Recommendations for management of patients with neuroendocrine liver metastases

            Many management strategies exist for neuroendocrine liver metastases. These strategies range from surgery to ablation with various interventional radiology procedures, and include both regional and systemic therapy with diverse biological, cytotoxic, or targeted agents. A paucity of biological, molecular, and genomic information and an absence of data from rigorous trials limit the validity of many publications detailing management. This Review represents the views from an international conference, for which 15 expert working groups prepared evidence-based assessments addressing specific questions, and from which an independent jury derived final recommendations. The aim of the conference was to review the existing approaches to neuroendocrine liver metastases, assess the evidence on which management decisions were based, develop internationally acceptable recommendations for clinical practice (when evidence was available), and make recommendations for clinical and research endeavours. This report represents the final clinical statements and proposals for future research.
              • Record: found
              • Abstract: found
              • Article: not found

              Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.

              Little is known about factors related to prognosis in patients with carcinoid disease. In this study we have tried to identify such factors. We have evaluated 301 consecutive carcinoid patients (256 midgut, 39 foregut and six hindgut) referred during 15 years for medical treatment with respect to tumor distribution, hormone production, prognostic factors and survival. Survival was significantly shorter in midgut carcinoid patients with > or = 5 liver metastases or with high levels of urinary 5-hydroxyindoleacetic acid, plasma chromogranin A or neuropeptide K. By univariate analysis, these variables together with the presence of carcinoid syndrome were related to a higher risk of dying. In multivariate analyses, performed in the 71 patients with full information on all variables, advanced age and plasma chromogranin A > 5000 micrograms/l were independent predictors of overall survival. Poor prognostic factors for midgut carcinoid patients were multiple liver metastases, presence of carcinoid syndrome and high levels of the tumor markers studied. In this study the only independent predictors of bad prognosis in midgut, carcinoid patients were advanced age, which however is inherently related to overall survival, and plasma chromogranin A > 5000 micrograms/l. Thus, chromogranin A may prove to be an important prognostic marker for patients with carcinoid tumors.

                Author and article information

                Journal
                Endocr Connect
                Endocr Connect
                EC
                Endocrine Connections
                Bioscientifica Ltd (Bristol )
                2049-3614
                January 2017
                09 January 2017
                : 6
                : 1
                : 33-38
                Affiliations
                [1 ]Univ Paris Diderot Sorbonne Paris Cité, Paris, France
                [2 ]INSERM UMR1149 CRI, Paris, France
                [3 ]Department of Radiology AP-HP, Clichy, France
                [4 ]Department of Gastroenterology and Pancreatology AP-HP, Clichy, France
                Author notes
                Correspondence should be addressed to M Zappa; Email: magaly.zappa@ 123456aphp.fr
                Article
                EC160092
                10.1530/EC-16-0092
                5302166
                28069898
                97781ad1-cb07-4675-8ff4-2e0cd515c802
                © 2017 The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 12 December 2016
                : 9 January 2017
                Categories
                Research

                neuroendocrine tumour,ct scan,liver metastases,liver burden

                Comments

                Comment on this article

                Related Documents Log